Cummins Strategy Partners
Strategic advisors to Pharma and Biotech for EU commercialisation
Empowering patient voices through access, insight, and collaboration.
At CSP, we believe that meaningful progress in healthcare depends on close partnership between patients, clinicians, and innovators. That’s why we dedicate part of our time and expertise to providing pro bono strategic support for patient organisations and rare disease charities working to improve access, awareness, and advocacy across Europe.
Our Commitment
CSP works with a small number of patient organisations each year on a no-fee basis, prioritising those addressing rare, ultra-rare, and high-unmet-need conditions. Our goal is to ensure that patient groups have access to the same level of insight and strategic thinking that supports industry stakeholders — creating a more balanced, informed, and collaborative healthcare ecosystems.
What We Offer
Our pro bono support focuses on helping patient-led organisations strengthen their impact through strategic clarity, data insight, and engagement planning. Typical areas of support include:
Access Pathway Guidance
Explaining how early access, compassionate use, and reimbursement systems operate across Europe.
Evidence and Data Planning
Helping define real-world data needs and patient-reported outcomes to strengthen advocacy cases.
Strategic communication
Supporting clear and ethical dialogues with regulators, payers and manufacturers.
Policy and Positioning Advice
Helping organisations contribute effectively to policy consultation and HTS Processes.
Workshop and Training Sessions
Building internal understanding of access pathways, pricing, and policy change.